2.4.1.214 | drug development |
RNA interference technology obtains a targeted down-regulation of the endogenous beta1,2-xylosyltransferase (XylT) and alpha1,3-fucosyltransferase (FucT) genes, whereby generating RNAi lines which are stable, viable and do not show any obvious phenotype, thus providing a robust tool for the production of therapeutically relevant glycoproteins in plants with a humanized N -glycan structure |
694619 |